1. Stocks
  2. Kabra Drugs Ltd.
  3. Swot
swot-logo

Kabra Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Kabra Drugs Ltd. has 25 Strengths, 3 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Price crossing above SMA20 today, and greater than SMA5

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent Highest Return Stocks over Five Years

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Turnaround companies- loss to profit QoQ

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

Highest Recovery from 52 Week Low

Stock with Low PE (PE < = 10)

RSI indicating price strength

High Volume, High Gain

Biggest Price Gainers from Open

Top Gainers

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low Piotroski Score : Companies with weak financials

Annual net profit declining for last 2 years

High Delivery Percentage